Literature DB >> 15476215

Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus.

Michael M Ward1.   

Abstract

OBJECTIVE: Patients with systemic lupus erythematosus (SLE) have increased risks of acute myocardial infarction (AMI) and cerebrovascular accident (CVA), but it is not known whether they have worse outcomes after AMI or CVA compared with patients without SLE. This study compared in-hospital mortality, length of stay, and other measures of severity (congestive heart failure or need for coronary artery bypass grafting after AMI; discharge to a skilled nursing facility after CVA) between patients with SLE and patients without SLE who were hospitalized for AMI or CVA.
METHODS: Data on all patients hospitalized in California with either AMI or CVA from 1996 to 2000 were abstracted from a state hospitalization database. Outcomes after AMI were compared between 519 patients with SLE and 214,771 patients without SLE, and outcomes after CVA were compared between 905 patients with SLE and 293,326 patients without SLE. Analyses were performed separately for men and women.
RESULTS: Among women with AMI, there were no differences in the risk of in-hospital mortality, long length of stay, or congestive heart failure between patients with SLE and those without SLE, but women with SLE were less likely to undergo coronary artery bypass grafting. Outcomes after AMI did not differ between men with SLE and men without SLE. Among women with CVA, there were no differences in outcomes between patients with SLE and patients without SLE. Men with SLE were almost twice as likely to have a long length of stay after CVA than were men without SLE.
CONCLUSION: Outcomes after AMI and CVA are generally similar between patients with SLE and those without SLE. Copyright 2004 American College of Rheumatology

Entities:  

Mesh:

Year:  2004        PMID: 15476215     DOI: 10.1002/art.20556

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Atherosclerotic vascular disease in the autoimmune rheumatologic patient.

Authors:  Rekha Mankad
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

2.  Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.

Authors:  Chao-Han Lai; Cheng-Yang Hsieh; April Barnado; Li-Ching Huang; Sheau-Chiann Chen; Liang-Miin Tsai; Yu Shyr; Chung-Yi Li
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

Review 3.  Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.

Authors:  Deborah P M Symmons; Sherine E Gabriel
Journal:  Nat Rev Rheumatol       Date:  2011-05-31       Impact factor: 20.543

4.  Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Tracy U Nguyen-Oghalai; Helen Wu; Terry A McNearney; Carl V Granger; Kenneth J Ottenbacher
Journal:  Arthritis Rheum       Date:  2008-07-15

5.  Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry.

Authors:  Kathleen Maksimowicz-McKinnon; Faith Selzer; Susan Manzi; Kevin E Kip; Suresh R Mulukutla; Oscar C Marroquin; Thomas C Smitherman; Lewis H Kuller; David O Williams; Mary Chester M Wasko
Journal:  Circ Cardiovasc Interv       Date:  2008-12       Impact factor: 6.546

6.  Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Qiuju Li; Li Su; Murray B Urowitz; Caroline Gordon; Sang-Cheol Bae; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; David A Isenberg; Anisur Rahman; Joan T Merrill; Paul Fortin; Dafna D Gladman; Ian N Bruce; Michelle Petri; Ellen M Ginzler; M A Dooley; Kristjan Steinsson; Rosalind Ramsey-Goldman; Asad A Zoma; Susan Manzi; Ola Nived; Andreas Jonsen; Munther A Khamashta; Graciela S Alarcón; Winn Chatham; Ronald F van Vollenhoven; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; Manuel Ramos-Casals; S Sam Lim; Murat Inanc; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Diane L Kamen; Anca Askanase; Chris Theriault; Vernon Farewell
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-01       Impact factor: 4.794

Review 7.  The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.

Authors:  Alessandro Durante; Sofia Bronzato
Journal:  J Clin Med Res       Date:  2015-04-08

8.  Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.

Authors:  Sharon Van Doornum; Megan Bohensky; Mark A Tacey; Caroline A Brand; Vijaya Sundararajan; Ian P Wicks
Journal:  Arthritis Res Ther       Date:  2015-02-27       Impact factor: 5.156

Review 9.  Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies.

Authors:  Marie Holmqvist; Julia F Simard; Kjell Asplund; Elizabeth V Arkema
Journal:  RMD Open       Date:  2015-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.